Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Market Cap$12.98B
Close$
$72.49
162.5% upside
Current Fair Value
162.5% upsideUndervalued by 162.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.98 Billion |
|---|---|
| Enterprise Value | $18.62 Billion |
| Dividend Yield | $0.7943 (2.73%) |
| Earnings per Share | $1.88 |
| Beta | 0.67 |
| Outstanding Shares | 446,691,515 |
| Avg 30 Day Volume | 2,435,332 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 11.43 |
|---|---|
| PEG | -5.49 |
| Price to Sales | 5.52 |
| Price to Book Ratio | 1.97 |
| Enterprise Value to Revenue | 7.91 |
| Enterprise Value to EBIT | 12.24 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.94 |
Revenue Sources
No data
ESG Score
No data